Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 18/20 | 0.64 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.51 |
| ▸ | STRADA | Q7RTN6 | 1/20 | 0.51 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4378016 | 0.89 | MAPK14 (0.80) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL4386893 | 0.83 | MAPK14 (0.71) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL29593336 | 0.83 | MAPK14 (0.71) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL4377058 | 0.83 | MAPK14 (0.81) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL29593364 | 0.83 | MAPK14 (0.81) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL13635341 | 0.81 | MAPK14 (0.68) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL4377476 | 0.81 | MAPK14 (0.71) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL6473434 | 0.81 | MAPK14 (0.84) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL4378292 | 0.80 | MAPK14 (0.72) | MAPK14ROCK2MAPK12MAPK11STRADA | |
| SCHEMBL29593450 | 0.79 | MAPK14 (0.88) | MAPK14ROCK2MAPK12MAPK11STRADA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490064-B1 | SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE | PHARMACIA CORP (US) | 2009-11-18 | — | — | EP | disclosed |